These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6867763)

  • 1. Anti-thrombin III levels in some Malaysian patients suspected of having acquired coagulation disorders.
    Tan SH; Doraisamy G; Noriah R; Lopez CG
    Singapore Med J; 1983 Feb; 24(1):33-6. PubMed ID: 6867763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of thrombin-antithrombin complexes in hypercoagulability conditions. Analysis of 182 cases].
    Zuazu-Jausoro I; Borrell M; Urrutia T; Oliver A; Montserrat I; Mateo J; Ribera L; Fontcuberta J
    Sangre (Barc); 1990 Oct; 35(5):375-9. PubMed ID: 2291147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 6. New diagnostic possibilities for the detection of thrombophilic states.
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):253-9. PubMed ID: 2465211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome.
    Onyemelukwe GC; Jibril HB
    Trop Geogr Med; 1992 Jan; 44(1-2):37-41. PubMed ID: 1496720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
    Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
    Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of the determination of thrombin-antithrombin-III complexes in hypercoagulability states].
    García Avello A; García Frade A; Sureda JL; Torrado MC
    Sangre (Barc); 1991 Apr; 36(2):163. PubMed ID: 1866654
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation abnormalities in diabetic patients undergoing renal transplantation.
    Reissell E; Lalla M; Höckerstedt K; Lindgren L
    Ann Chir Gynaecol; 1994; 83(3):251-5. PubMed ID: 7857071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulability as a cause of sudden neurosensory hearing loss.
    Zajtchuk JT; Falor WH; Rhodes MF
    Otolaryngol Head Neck Surg (1979); 1979; 87(2):268-73. PubMed ID: 503500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombin III determinations in internal medicine and surgery].
    Schmitz-Huebner U
    Med Lab (Stuttg); 1980 Sep; 33(9):232-5. PubMed ID: 7442606
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III (clinical aspects and methodology)].
    Abildgaard U
    Ric Clin Lab; 1978; 8 Suppl 2():90-7. PubMed ID: 106453
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy.
    Fujii K; Usuki A; Kan-No Y; Ohgou N
    J Dermatol; 2008 May; 35(5):308-10. PubMed ID: 18477235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of oxidative stress as a component of critical states in the genesis of hemostatic disorders].
    Pasechnik IN; Azizov IuM; Nikushkin EV; Barinov VG; Larionov AS
    Anesteziol Reanimatol; 2001; (3):41-3. PubMed ID: 11510357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 19. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of a concentrate of antithrombin III and disaggregants in the preoperative preparation of patients with pulmonary tuberculosis].
    Priĭmak AA; Makinskiĭ AI; Ivan'ko TP; Makarova VV
    Vrach Delo; 1990 May; (5):73-4. PubMed ID: 2396401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.